Literature DB >> 22613171

Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4+CD25(high) regulatory T cell frequencies in heroin user.

Gina-Lucia Riss1, Dae-In Chang, Carolin Wevers, Astrid M Westendorf, Jan Buer, Norbert Scherbaum, Wiebke Hansen.   

Abstract

There is an increasing body of evidence that heroin addiction is associated with severe alterations in immune function, which might contribute to an increased risk to contract infectious diseases like hepatitis B and C or HIV. However, the impact of heroin consumption on the CD4(+) T cell compartment is not well understood. Therefore, we analyzed the frequency and functional phenotype of CD4(+) T cells as well as immune-suppressive CD4(+)CD25(high) regulatory T cells (Tregs) isolated from the peripheral blood of opiate addicts currently abusing heroin (n=27) in comparison to healthy controls (n=25) and opiate addicts currently in opioid maintenance treatment (OMT; n=27). Interestingly, we detected a significant increase in the percentage of CD4(+)CD25(high) Tregs in the peripheral blood of heroin addicted patients in contrast to patients in OMT. The proliferative response of CD4(+) T cells upon stimulation with anti-CD3 and anti-CD28 antibodies was significantly decreased in heroin users, but could be restored by depletion of CD25(high) regulatory T cells from CD4(+) T cells to similar values as observed from healthy controls and patients in OMT. These results suggest that impaired immune responses observed in heroin users are related to the expansion of CD4(+)CD25(high) Tregs and more importantly, can be restored by OMT.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613171     DOI: 10.1016/j.bbi.2012.05.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  10 in total

1.  Effects of fentanyl anesthesia and sufentanil anesthesia on regulatory T cells frequencies.

Authors:  Li Gong; Qian Qin; Lei Zhou; Wen Ouyang; Yanshuang Li; Yuhui Wu; Yunli Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial.

Authors:  Yongliang Feng; Jing Shi; Linying Gao; Tian Yao; Dan Feng; Dan Luo; Zhansheng Li; Yawei Zhang; Fuzhen Wang; Fuqiang Cui; Li Li; Xiaofeng Liang; Suping Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-16       Impact factor: 3.452

3.  Whole Transcriptome Sequencing of Peripheral Blood Shows That Immunity/GnRH/PI3K-Akt Pathways Are Associated With Opioid Use Disorder.

Authors:  Qi Dai; Shan-Shan Pu; Xue Yang; Chang Li; Yafei He; Xiaobo Liu; Gang Wang
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435

4.  Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency.

Authors:  Germán Gustavo Gornalusse; Lucia N Vojtech; Claire N Levy; Sean M Hughes; Yeseul Kim; Rogelio Valdez; Urvashi Pandey; Christina Ochsenbauer; Rena Astronomo; Julie McElrath; Florian Hladik
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.818

Review 5.  Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.

Authors:  Jennifer M Loftis; Marilyn Huckans
Journal:  Pharmacol Ther       Date:  2013-04-28       Impact factor: 12.310

Review 6.  Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.

Authors:  Matias Jaureguiberry-Bravo; Rebecca Wilson; Loreto Carvallo; Joan W Berman
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

7.  Impact of illicit opioid use on T cell subsets among HIV-infected adults.

Authors:  E Jennifer Edelman; Kaku So-Armah; Debbie M Cheng; Margaret F Doyle; Sharon M Coleman; Carly Bridden; Natalia Gnatienko; Dmitry A Lioznov; Elena Blokhina; Matthew S Freiberg; Evgeny M Krupitsky; Brinda Emu; Jeffrey H Samet
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

Review 8.  The Effects of Opioids on HIV Neuropathogenesis.

Authors:  Aniella Murphy; John Barbaro; Pablo Martínez-Aguado; Vanessa Chilunda; Matias Jaureguiberry-Bravo; Joan W Berman
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 9.  Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir.

Authors:  Shilpa Sonti; Kratika Tyagi; Amit Pande; Rene Daniel; Adhikarimayum Lakhikumar Sharma; Mudit Tyagi
Journal:  Vaccines (Basel)       Date:  2022-01-27

10.  Transgenic increase in the β-endorphin concentration in cerebrospinal fluid alleviates morphine-primed relapse behavior through the μ opioid receptor in rats.

Authors:  Yan He; Yugang Lu; Yang Shen; Feixiang Wu; Xuewu Xu; Erliang Kong; Zhangxiang Huang; Yuming Sun; Weifeng Yu
Journal:  J Med Virol       Date:  2019-02-19       Impact factor: 2.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.